To address this, Libutti et al. synthesized PEGylated colloidal gold nanoparticles to carry recombinant human TNF-α and found that it successfully targeted tumor cells, reduced IFP, and remained nontoxic until doses three times higher than systemically administered TNF-α.125. The gene discussed is TNF; the disease is neoplasm.